Display:
Providers:
PetVivo Holdings, Inc. is a development-stage company. The Company is a biomedical device company focused on licensing and commercialization of medical devices and therapeutics for pets. The Company's operating subsidiary, PetVivo, Inc., (PetVivo) is engaged in the business of acquiring/in-licensing and adapting human biomedical technology and products for commercial sale in the veterinary market to treat pets and other animals suffering from arthritis and other painful affliction. As of March 31, 2015, PetVivo's pipeline included 17 therapeutic devices for both veterinary and human clinical applications. PetVivo's pipeline includes VD-01, VD-02 and VD-06, which are indicated for osteoarthritis, and VD-04, which is indicated for urinary incontinence, among others. Its subsidiary also includes Gel-Del Technologies, Inc., which has completed a pivotal clinical trial using their thermoplastic biomaterial as a dermal filler for human cosmetic applications.
|
|
|
|
|
Yesterday's News, January 26, 2023 | ||
---|---|---|
January 23, 2023 | ||
January 17, 2023 | ||
January 12, 2023 | ||
January 09, 2023 | ||
December 28, 2022 | ||
December 19, 2022 | ||
December 05, 2022 | ||
November 16, 2022 | ||
November 11, 2022 | ||
November 10, 2022 | ||
PetVivo Reports Second Quarter of Fiscal 2023 Financial Results(Globe Newswire) | ||
November 09, 2022 | ||
November 04, 2022 | ||
November 03, 2022 | ||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.